Memory, more than the roadmap, limits Chinese AI compute. Huawei’s 950DT reportedly passed 250,000 yuan while CXMT’s IPO left 36.8 billion yuan unassigned.
Memory, more than the roadmap, limits Chinese AI compute this week, and the evidence shows the shortage priced in one place and unassigned in another. At Huawei Connect on September 17, Huawei moved its next accelerator forward three quarters, and deputy chairman Eric Xu told reporters that China will not catch up with demand for AI hardware, including memory chips and optical components, until 2030. The chip Chinese labs are lining up for, the memory-heavy Ascend 950DT, has reportedly been repriced past 250,000 yuan, while CXMT, the DRAM maker that listed in Shanghai in July, reported its final IPO proceeds at 66.6 billion yuan and left 36.8 billion of it above the three projects it named. For an investor sizing 2027 supply, the number that matters is not a launch date but who is funded to build the memory that goes on the chip. No consensus estimate of either company’s output of high-bandwidth memory, or HBM, turned up in this pass, so this issue tests a proposition and does not claim a mispricing.
The date moved and the volume did not. Huawei’s own release puts the Ascend 960DT in the first quarter of 2027 and the 960PR in the third, three quarters and one quarter ahead of plan. It also launched a new pod, the Atlas 960E SuperPoD, a rack-scale cluster that works as one machine and scales to 4,096 chips. The earlier roadmap keynote described an Atlas 960 SuperPoD of up to 15,488 chips for the fourth quarter of 2027. Neither 2026 page says whether the new pod replaces that one or sits beside it, and neither gives the 960E a ship date, so this issue does not call the pod smaller. They are different products. All three Huawei pages were read in full this session; anything marked Reported below was not. What the pages do not contain is a count of 960DT chips that will exist in 2027. That count, not the date, sets what a lab can plan an inference fleet around.
The price sheet says what is short. Reuters reported the indicated price of the 950DT on September 10 at above 250,000 yuan, up 20 to 50 percent from quotes two months earlier, with the older 950PR above 80,000 yuan from about 60,000 at the start of the year [Reported: Reuters, anonymous sources, Huawei did not respond]. Bloomberg put the 950DT rise at about 60 percent over three months [Reported: Bloomberg, anonymous sources]. The two agree on the level and differ on the rise, which each measures over a different window, so the price is the fact and the percentage is not. Cambricon, a listed rival, repriced its unreleased next chip by 20 to 30 percent, per Reuters, so the squeeze is not only Huawei’s. Huawei cited tight component supply to customers, per Bloomberg. Reuters’ sources put the squeeze on memory: Chinese chipmakers lean on grey-market HBM that costs several times the price paid outside China, and Huawei has not said where its own HBM is made. In July this publication tied the inference ceiling to the 950DT’s fourth-quarter date and said the ceiling would stay if the chip slipped or shipped thin. The date still stands. The first evidence on volume points to scarcity: DeepSeek plans to deploy at least 160,000 of these chips, more than Huawei can yet supply [Reported: Bloomberg, no company confirmation found in this pass]. At the indicated price, 160,000 chips times 250,000 yuan is roughly 40 billion yuan for one lab, before order-size discounts and auxiliary equipment.
The memory maker has cash and no named HBM line. CXMT’s May declaration draft named three projects for 29.5 billion yuan of proceeds: a memory wafer line upgrade, a DRAM technology upgrade and DRAM forward research. None is called HBM. The raise then came in larger. The final proceeds announcement of August 27 puts gross proceeds at 66.6 billion yuan and net at 66.3 billion, and says the amount above the planned figure will be used after review and disclosure. Net proceeds of 66.3 billion less the 29.5 billion planned leaves 36.8 billion yuan not yet assigned. The excess exists because investors paid 8.66 yuan a share against about 4.41 implied by the draft’s plan, which is 29.5 billion divided by 6.69 billion planned shares, and the stock stayed above 8.66 yuan through the exercise window, so the over-allotment ran in full. Cash does not look like the constraint at CXMT. Its late-August half-year filing shows 150.3 billion yuan of revenue, 117.1 billion of profit before tax and 131.2 billion of operating cash flow, all unaudited. The May draft attributes the price surge behind such numbers to compute demand and larger makers reallocating capacity, so on this reading the same memory shortage that lifts Huawei’s price sheet is being paid to CXMT as DRAM margin. In the documents read, neither company says whether CXMT supplies Huawei, and the project names do not say whether forward research includes HBM. The filings show cash in hand. They do not show HBM output, which is where Reuters’ sources place the shortage, and no document read this week quantifies it. This item rests on the May draft and the August announcement; the July listing prospectus and the full half-year report were not checked this session.
None of this says Huawei’s roadmap is hollow or that CXMT will not build HBM. Xu named optical components alongside memory, Huawei’s manufacturing output is also limited [Reported: Bloomberg], and CXMT’s margin reflects a DRAM cycle that would run without Huawei. This issue follows memory because that is where the price reporting points. Huawei executives also said the company now holds a larger share of China’s AI chip market than Nvidia [Reported: Bloomberg], the 960DT date may hold, and CXMT’s board may yet assign the 36.8 billion yuan to HBM. The gap is between a date Huawei has announced and a memory supply chain that no document quantifies.
What would settle it. The nearest test is CXMT’s third-quarter report, expected by the end of October, together with the board’s plan for the unassigned 36.8 billion yuan. An HBM line in either would show domestic memory being funded, which is the precondition for the 950DT’s price to ease. Money parked, or spent on commodity DRAM, would make Huawei’s price sheet the durable reading: supply, not capital, sets 2027 volume. The second test is Huawei’s fourth quarter. If the 950DT ships in the quarter Huawei promised but the indicated price holds above 250,000 yuan and DeepSeek’s order stays unfilled, the July ceiling has moved from date to volume and has not lifted. If the price falls back, this issue was early. A cheaper tell is whether Huawei restates the 15,488-chip pod on its roadmap, which would say the 960E is a step and not a replacement.
ICM Weekly is research, not investment advice.